Point-of-care testing in an organ procurement organization donor management setting

Authors: Baier, K A1; Markham, L E1; Flaigle, S P1; Nelson, P W1; Shield, C F1; Muruve, N A1; Aeder, M I1; Murillo, D1; Bryan, C F1

Source: Clinical Transplantation, Volume 17, Supplement 9, June 2003 , pp. 48-51(4)

Publisher: Blackwell Publishing

Key:
Free Content - Free Content
New Content - New Content
Subscribed Content - Subscribed Content
Free Trial Content - Free Trial Content

Abstract:

Baier KA, Markham LE, Flaigle SP, Nelson PW, Shield CF, Muruve NA, Aeder MI, Murillo D, Bryan CF. Point-of-care testing in an organ procurement organization donor management setting.

Clin Transplant 2003: 17 (Suppl. 9): 48-51. © Blackwell Munksgaard, 2003 Abstract: Purpose: 

Our organ procurement organization (OPO) evaluated the clinical and financial efficacy of point-of-care testing (POCT) in management of our deceased organ donors. Methods:

Before we implemented point-of care testing with the i-STAT into routine clinical donor management, we compared the i-STAT result with the result from the respective donor hospital lab (DHL) for certain analytes on 15 consecutive donors in our OPO from 26 March to 14 May 2001. The financial impact was studied by reviewing 77 donors from July 2001 to March 2002. Results:

There was a strong correlation for each analyte between the POC and DHL test results with r-values as follows: pH 0.86; PCO2 = 0.96; PO2 = 0.98; sodium = 0.98; potassium = 0.95; chloride = 0.94; BUN = 0.98; glucose = 0.92; haematocrit = 0.87 and creatinine = 0.95. Since our OPO coordinators began using i-STAT in their routine clinical management of organ donors, they can now more quickly maximize oxygenation and fluid management of the donor and make extra-renal placement calls sooner. Finally, since we are no longer being billed for the testing performed on the i-STAT, average financial savings to our OPO are $733 per case. Conclusions:

Point-of-care testing in management of our OPO donors provides a result that is equivalent to that of the donor hospital lab, has quicker turn-around time than the donor hospital laboratory, allowing more immediate clinical management decisions to be made so that extra-renal offers may begin sooner.

Keywords: i-STAT; donor management; test turn-around time

Document Type: Research article

DOI: 10.1034/j.1399-0012.17.s9.9.x

Affiliations: 1: Midwest Transplant Network, Westwood, KS, USA

The full text electronic article is available for purchase. You will be able to download the full text electronic article after payment.

$50.39 plus tax      Refund Policy

 

OR

Back to top

Key:
Free Content - Free Content
New Content - New Content
Subscribed Content - Subscribed Content
Free Trial Content - Free Trial Content
Share this item with others: These icons link to social bookmarking sites where readers can share and discover new web pages.
Page Help Click here for Page Help
Shopping cart
Tools
Sign in






Need to register?
Sign up here
Text size: A | A | A | A